Evidence map›Paper›PMID 28393592›Full record

ArticleRenal failure2017

Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells.

Kun Ye, Qiaoyu Wei, Zhifeng Gong, Yunfeng Huang, Hong Liu, Ying Li, Xiaomei Peng

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Complex Crystal Structure Determination andFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kun Yea Department of Nephrology , The People's Hospital of Guangxi Zhuang Autonomous Region , Guangxi , China.
Qiaoyu Weia Department of Nephrology , The People's Hospital of Guangxi Zhuang Autonomous Region , Guangxi , China.
Zhifeng Gonga Department of Nephrology , The People's Hospital of Guangxi Zhuang Autonomous Region , Guangxi , China.
Yunfeng Huanga Department of Nephrology , The People's Hospital of Guangxi Zhuang Autonomous Region , Guangxi , China.
Hong Liub Department of Nephrology , The Second Xiangya Hospital of Central South University , Hunan , China.
Ying Lib Department of Nephrology , The Second Xiangya Hospital of Central South University , Hunan , China.
Xiaomei Penga Department of Nephrology , The People's Hospital of Guangxi Zhuang Autonomous Region , Guangxi , China.
The People's Hospital of Guangxi Zhuang Autonomous Region · CNCentral South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsNorcantharidin (NCTD) regulates immune system function and reduces proteinuria. We sought to investigate the effect of NCTD on proliferation, apoptosis and cell cycle of cultured human mesangial cells (HMC) in vitro.

methodsHMC cells were divided into a normal control group, and various concentrations of NCTD group (2.5, 5, 10, 20, or 40 μg/mL). Cell proliferation was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, apoptosis was detected by Annexin V/propidium iodide (PI) assays, and morphological analysis was performed by Hoechest 33258 staining. Finally, cell cycle was analyzed by flow cytometry.

resultsNCTD dose and time dependently inhibits HMC proliferation significantly (p < .05). Apoptosis dose and time dependently increased after NCTD treatment. Cell-cycle analysis revealed that the number of cells in the G2 phase increased significantly, whereas the fraction of cells in the S phase decreased, especially 24 h after 5 μg/ml NCTD treatment.

conclusionNCTD inhibits HMC cell proliferation, induces apoptosis, and affects the cell cycle.

Indexed as

ApoptosisBridged Bicyclo Compounds, HeterocyclicCell CycleCell Line, TumorCell ProliferationHumansMesangial CellsBridged Bicyclo Compounds, Heterocyclicnorcantharidinapoptosiscell cycleMesangial cellnorcantharidinproliferation

Identifiers

PMID28393592
PMCPMC6014529
OpenAlexW2607469626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.